Skip to main content
Andrew Zelenetz, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

AndrewDZelenetzMDPhD

Oncology • New York, NY

Hematologic Oncology

Medical Director, Quality Informatics Attending Physician, Lymphoma Service Professor of Medicine, Weill Cornell Medicine

Request Appointment

Overview of Dr. Zelenetz

Dr. Andrew Zelenetz is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Cancer Center. He received his medical degree from Harvard Medical School and has been in practice 33 years. Dr. Zelenetz accepts several types of health insurance, listed below. He is one of 464 doctors at Memorial Sloan Kettering Cancer Center and one of 464 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • Stanford University Medical Center
    Stanford University Medical CenterFellowship, Research Fellow in Oncology, 1987 - 1991
  • Stanford Health Care
    Stanford Health CareFellowship, Clinical Fellow In Oncology, 1986 - 1989
  • Stanford Health Care
    Stanford Health CareResidency, Internal Medicine, 1985 - 1986
  • Stanford Health Care
    Stanford Health CareInternship, Internal Medicine, 1984 - 1985
  • Harvard Medical School
    Harvard Medical SchoolClass of 1984
  • Harvard Graduate School of Arts & Sciences Division of Medical Science
    Harvard Graduate School of Arts & Sciences Division of Medical SciencePhD, Experimental Pathology, 1984
  • Harvard College
    Harvard CollegeAB, Biochemical Sciences, Magna cum Laude, 1977

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 1991 - 2025
  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • CT State Medical License
    CT State Medical License 2024 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2002-2015
  • Top Doctors: New York Metro Area Castle Connolly, 2003-2014
  • America's Top Doctors Castle Connolly, 2003-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Venetoclax plus R- or G-CHOP in Non-Hodgkin Lymphoma: Results from the CAVALLI Phase 1b Trial  
    Andrew D Zelenetz, Andre Goy, Mehrdad Mobasher, Carla Casulo, Blood
  • Clonal Diversity Predicts Adverse Outcome in Chronic Lymphocytic Leukemia  
    Vincent Miller, Tariq Mughal, Nicole Lamanna, Andrew Zelenetz, Mark L Heaney, Mark G Frattini, Nature
  • Real World Outcomes and Management Strategies for Venetoclax-Treated Chronic Lymphocytic Leukemia Patients in the United States  
    Arun K Singavi, Andrew Zelenetz, Nicole Lamanna, Bruce D Cheson, Richard R Furman, Jakub Svoboda, Stephen J Schuster, John N Allan, Chaitra S Ujjani, Haematologica
  • Join now to see all

Books/Book Chapters

  • Methods of Enzymology. 
    Chapter: Efficient construction of complex directional cDNA libraries in a SfiI cassette 
    Page 517 - 530Zelenetz ADEditors: Wu R.Academic Press Inc, San Diego, CA
  • The Non-Hodgkin’s Lymphomas. 
    Chapter: The pathogenesis of the low grade B-cell lymphomas 
    Zelenetz AD, Brodeur DEditors: Magrath, I.Edward Arnold, Kent, United KingdomEdition 2,
  • Oncology. 
    Chapter: The non-Hodgkin’s Lymphomas – An Evidence Based Approach 
    Zelenetz, A.D., Horwitz S.MEditors: Chang, A.E., Ganz P.A., Hayes, D.F., Kinsella T., Pass, H.I., Schiller, J.H., Stone, R.M., Strecher.
  • Join now to see all

Abstracts/Posters

  • Genomic Profiling of Mantle Cell Lymphoma Suggests Poor-Risk Profile Is Present at Diagnosis and Does Not Arise By Tumor Evolution
    Andrew D. Zelenetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma
    Andrew D. Zelenetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
    Andrew D. Zelenetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Results of the PI3Kδ inhibitor ME-401 alone or with rituximab in relapsed/refractory (R/R) follicular lymphoma (FL). 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • 17th International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas and Myeloma® 
    Physicians' Education Resource, LLC, New York, New York - 2/15/2013

Press Mentions

  • High-Dose Chemo, ASCT Improves Survival in Primary CNS Lymphoma
    High-Dose Chemo, ASCT Improves Survival in Primary CNS LymphomaDecember 14th, 2022
  • NCCN's New Patient Guidelines for Marginal Zone Lymphoma Help Patients and Caregivers Better Understand a Rare Form of Blood Cancer
    NCCN's New Patient Guidelines for Marginal Zone Lymphoma Help Patients and Caregivers Better Understand a Rare Form of Blood CancerSeptember 13th, 2022
  • NCCN's New Patient Guidelines for Marginal Zone Lymphoma Help Patients and Caregivers Better Understand a Rare Form of Blood Cancer
    NCCN's New Patient Guidelines for Marginal Zone Lymphoma Help Patients and Caregivers Better Understand a Rare Form of Blood CancerSeptember 12th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Andrew Zelenetz, Dr. Andrew Zelenetz, MD, Dr. A Zelenetz, Dr. Andrew D Zelenetz